Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...

There will be about 299,010 new cases of prostate cancer diagnosed this year, according to the American Cancer Society.

The Streetjournal Magazine is an online investigating media house that specializes on systematic, serious crimes, political ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...

A groundbreaking new cancer treatment, hailed by patients as "game-changing", will be available via the NHS from today.

A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.

A team of University of Kentucky Markey Cancer Center researchers have found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug treatment.

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

To say the last few years of Olivia Munn’s life have been a rollercoaster doesn’t fully capture what she’s been through.

A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.